Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4039-4039
Keyword(s):
Phase Ii
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4058-4058
◽